CHROMTH-RO
Roche
Chromozym TH
Synonym(s):
thrombin substrate
Sign Into View Organizational & Contract Pricing
Select a Size
20 MG
$362.95
100 MG
$1,480.00
$362.95
List Price$427.00Save 15%Web-Only Promotion
Available to ship onApril 22, 2025Details
All Photos(1)
Select a Size
Change View
20 MG
$362.95
100 MG
$1,480.00
About This Item
UNSPSC Code:
12352204
$362.95
List Price$427.00Save 15%Web-Only Promotion
Available to ship onApril 22, 2025Details
Recommended Products
assay
90% (Tosyl-Gly-Pro-Arg-4-nitranilide acetate (enzymatic))
90% (enzymatic)
Quality Level
form
powder
mol wt
Mr 662.62
packaging
pkg of 100 mg (11585398001)
pkg of 20 mg (10206849001)
manufacturer/tradename
Roche
shipped in
ambient
storage temp.
20-25°C
Related Categories
General description
Chromozym® TH is a chromophoric substrate mostly used to detect thrombin activity[1]†
Tosyl-Gly-Pro-Arg-4-nitranilide acetate
Application
Use Chromozym® TH as a substrate for the determination of serine proteases, specifically thrombin in aqueous solutions.[1]
Quality
Contaminant: 1% free 4-nitraniline
Sequence
Tosyl-glycyl-polyl-arginine-4-nitranilideacetate
Preparation Note
Working concentration: Approximately 0.2 mM
Storage conditions (working solution): 2 to 8 °C
A substrate solution (approx. 2 mM) is stable for at least 4 weeks if stored at 2 to 8 °C.
Storage conditions (working solution): 2 to 8 °C
A substrate solution (approx. 2 mM) is stable for at least 4 weeks if stored at 2 to 8 °C.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Legal Information
Chromozym is a registered trademark of Pentapharm AG, Basel
Storage Class
11 - Combustible Solids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
E Perzborn et al.
Journal of thrombosis and haemostasis : JTH, 3(3), 514-521 (2005-03-08)
BAY 59-7939 is an oral, direct Factor Xa (FXa) inhibitor in development for the prevention and treatment of arterial and venous thrombosis. BAY 59-7939 competitively inhibits human FXa (K(i) 0.4 nm) with > 10 000-fold greater selectivity than for other
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
